We use cookies for a better user experience. Read our Privacy Policy

I Agree

Transfusion Technology Market Insights, 2018-2026

Transfusion Technology Market (Product - Instruments (Apheresis System and Multicomponent Collection Systems, Cell Processing Systems, Cell Expansion Systems, Auto transfusion Devices), Disposables and Consumables; End user - Hospitals, Blood Banks, Biotechnology and Pharmaceutical Companies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Transfusion Technology Market - Snapshot

A transfusion technology device is an electromechanical device that ensures the safety of a patient during blood transfusion and donation. Transfusion technology devices can be classified as apheresis system, blood component separators, cell expansion system, and auto transfusion devices. Apheresis is a procedure performed either for donation of a blood component or for treatment of a disease by removal of the diseased or disease-causing blood component. Whole blood is extracted from the donor or patient’s body, processed through the apheresis machine, and the desired blood components are separated based on their molecular weight, size, and affinity for particular substance, while the remaining blood is transfused back to the donor or patient. Multicomponent collection system, also known as blood component separator, is a device that processes and separates blood components. Automated cell expansion systems are used for the development of cells for cell therapy. Cell expansion is an important step in the manufacture of cell types. The automated cell expansion system is a closed cell bag bioreactor, which is used to culture the cell under controlled environmental condition with perfusion. The auto transfusion device is an electromechanical device that transfers the patient’s own blood during and after surgery. Rise in the incidence of chronic disorders among the geriatric population is likely to drive the need for safer transfusion devices and transfusion technology, which in turn is projected to propel the global transfusion technology market in the near future. 

transfusion technology market

The global transfusion technology market is characterized by an increase in the incidence of chronic diseases across the world. The market is expanding at a rapid pace, due to implementation of government guidelines about safety of transfusion. The global transfusion technology market is projected to expand at a rapid pace from 2018 to 2026. 

Increase in the geriatric population, which is prone to chronic diseases, large patient pool in developing countries requiring better health care facilities, and investments by public and private players in R&D on transfusion technology to ensure elimination of transfusion-associated infections and reduce the risk of transfusion reactions are key factors that are likely to drive the global transfusion technology market during the forecast period. However, lengthy procedure of obtaining regulatory approval, significant investments required in the innovation of transfusion technology, and increase in minimally invasive procedure that leads to low blood loss are likely to restrain the global market during the forecast period. Transfusion technology devices are gaining popularity among health care professionals, as these have proved to be effective in reducing transfusion reaction. Rising investments for innovation in transfusion technology and partnerships for co-development and commercialization of these devices are expected to fuel the global transfusion technology market in the near future. 

In terms of product, the global transfusion technology market has been classified into instruments and disposables & consumables. The instruments segment has been further bifurcated into apheresis system & multicomponent collection systems, cell processing systems & cell expansion systems, auto transfusion devices, and others. The others segment includes tube sealing system, sterile tubing welder, mixer technology, and point of care hemoglobin meters. The cell processing systems & cell expansion systems segment is projected to dominate the market during the forecast period due to advancements in the treatment of cancer, such as cell therapy. The auto transfusion devices segment is projected to expand at a significant pace during the forecast period. Expansion of the segment can be attributed to the increase in adoption of auto transfusion devices, as the risk associated with transfusion of allogeneic blood is reduced in these devices. Moreover, presence of key companies engaged in R&D and manufacture of innovative and technologically advanced transfusion devices boosts the global market. Furthermore, initiatives by public and private organizations that are aimed at spreading awareness about advantages of blood donation among people have led to a rise in the number of donors. The relatively stable growth rate of the instrument segment can be ascribed to the ‘as it is a capital investment’ in developing countries and stringent regulations regarding manufacture and approval. The disposable & consumables segment is anticipated to expand at an above-average growth rate during the forecast period, due to the high use of these transfusion technology devices by end-users. This is due to the implementation of stringent guidelines by government organizations to reduce the prevalence of transfusion-associated infection. Apheresis devices are predominantly utilized in hospitals and public & private blood banks for blood donation. End-users are increasingly preferring apheresis devices and multicomponent collection systems due to a rise in the demand for therapeutic apheresis. 

Based on end-user, the global transfusion technology market has been classified into hospitals, blood bank, biotechnology & pharmaceutical companies, and others. The blood banks segment is expected to dominate the global transfusion technology market during the forecast period. In terms of region, the global transfusion technology market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a major share of the global market in 2017. Europe was another significant market for transfusion technology devices in 2017. Developed health care infrastructure, high rate of adoption of technologies, and relatively high paying capacity of patients in North America and Europe, as compared to those in developing countries, offer growth opportunities to new market entrants. This led the regions to hold a high share in the global market. Considerable expansion of the medical industry in India and China and investments made by global companies in Asia Pacific for establishment of sales subsidiaries, in order to provide support and services to existing customers and attract new customers, are expected to propel the transfusion technology market in Asia Pacific in the next few years. 

Major players operating in the global transfusion technology market are Haemonetics Corporation, Inc., Medtronic plc, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Cerus Corporation, Fresenius Kabi AG (Fresenius SE & Co. KGaA), GE Healthcare, Miltenyi Biotec, TERUMO BCT, and LivaNova PLC.

The global transfusion technology market has been segmented as follows: 

Product

  • Instruments
    • Apheresis System & Multicomponent Collection Systems
    • Cell Processing Systems & Cell Expansion Systems
    • Auto transfusion Devices
    • Others
  • Disposables & Consumables 

End-user

 

  • Hospitals
  • Blood Banks
  • Biotechnology & Pharmaceutical Companies
  • Others 

Region

 

  • North America
    • U.S
    • Canada
  • Europe
    • U.K
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Transfusion Technology

4. Market Overview
     4.1. Introduction
            4.1.1. Product Definition
            4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Transfusion Technology Market Analysis and Forecast, 2016–2026
            4.4.1. Market Revenue Projections (US$ Mn)
     4.5. Porter’s Five Force Analysis

5. Market Outlook
     5.1. Technological Advancement  in Apheresis System & Multi-Component Separator Systems 
     5.2. Key Trends of Transfusion Technology

6. Global Transfusion Technology Analysis and Forecast, by Product 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Global Transfusion Technology Market Value Forecast, by Product, 2016–2026
            6.3.1. Instruments
                     6.3.1.1. Apheresis System & Multicomponent Collection Systems
                     6.3.1.2. Cell Processing Systems & Cell Expansion Systems 
                     6.3.1.3. Auto Transfusion Devices
                     6.3.1.4. Others 
            6.3.2. Disposables & Consumables
     6.4. Global Transfusion Technology Market Attractiveness, by Product 

7. Global Transfusion Technology Market Analysis and Forecast, by  End-user 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Global Transfusion Technology Market Value Forecast, by End-user, 2016–2026
            7.3.1. Hospitals 
            7.3.2. Blood Banks 
            7.3.3. Biotechnology & Pharmaceutical Companies 
            7.3.4. Others 
     7.4. Global Transfusion Technology Market Attractiveness, by End-user 

8. Global Transfusion Technology Analysis and Forecast, by Region
     8.1. Key Findings
     8.2. Global Transfusion Technology Market Value Forecast, by Region
            8.2.1. North America 
            8.2.2. Europe 
            8.2.3. Asia Pacific 
            8.2.4. Latin America 
            8.2.5. Middle East & Africa 
     8.3. Global Transfusion Technology Market Attractiveness, by Region

9. North America Transfusion Technology Analysis and Forecast
     9.1. Introduction
            9.1.1. Key Findings
     9.2. North America Transfusion Technology Market Value Forecast, by Product, 2016–2026
            9.2.1. Instruments 
                     9.2.1.1. Apheresis System & Multicomponent Collection Systems
                     9.2.1.2. Cell Processing Systems & Cell Expansion Systems 
                     9.2.1.3. Auto Transfusion Devices
                     9.2.1.4. Others 
            9.2.2. Disposables & Consumables
     9.3. North America Transfusion Technology Market Value Forecast, by  End-user, 2016–2026
            9.3.1. Hospitals 
            9.3.2. Blood Banks 
            9.3.3. Biotechnology & Pharmaceutical Companies 
            9.3.4. Others 
     9.4. North America Transfusion Technology Market Value Forecast, by Country, 2016–2026
            9.4.1. U.S.
            9.4.2. Canada     
     9.5. North America Transfusion Technology Market Attractiveness Analysis 
            9.5.1. By Product 
            9.5.2. By  End-user 
            9.5.3. By Country

10. Europe Transfusion Technology Analysis and Forecast
     10.1. Introduction
            10.1.1. Key Findings
     10.2. Europe Transfusion Technology Market Value Forecast, by Product, 2016–2026
            10.2.1. Instruments
                     10.2.1.1. Apheresis System & Multicomponent Collection Systems
                     10.2.1.2. Cell Processing Systems & Cell Expansion Systems 
                     10.2.1.3. Auto Transfusion Devices
                     10.2.1.4. Others 
            10.2.2. Disposables & Consumables
     10.3. Europe Transfusion Technology Market Value Forecast, by  End-user, 2016–2026
            10.3.1. Hospitals 
            10.3.2. Blood Banks 
            10.3.3. Biotechnology & Pharmaceutical Companies 
            10.3.4. Others 
     10.4. Europe Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
            10.4.1. Germany
            10.4.2. U.K.
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Rest of Europe
     10.5. Europe Transfusion Technology Market Attractiveness Analysis 
            10.5.1. By Product 
            10.5.2. By  End-user 
            10.5.3. By Country/Sub-region

11. Asia Pacific Transfusion Technology Analysis and Forecast
     11.1. Introduction
            11.1.1. Key Findings
     11.2. Asia Pacific Transfusion Technology Market Value Forecast, by Product, 2016–2026
            11.2.1. Instruments
                     11.2.1.1. Apheresis System & Multicomponent Collection Systems
                     11.2.1.2. Cell Processing Systems & Cell Expansion Systems 
                     11.2.1.3. Auto Transfusion Devices
                     11.2.1.4. Others 
            11.2.2. Disposables & Consumables 
     11.3. Asia Pacific Transfusion Technology Market Value Forecast, by  End-user, 2016–2026
            11.3.1. Hospitals 
            11.3.2. Blood Banks 
            11.3.3. Biotechnology & Pharmaceutical Companies 
            11.3.4. Others 
     11.4. Asia Pacific Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
            11.4.1. China
            11.4.2. Japan
            11.4.3. India
            11.4.4. Australia & New Zealand
            11.4.5. Rest of Asia Pacific
     11.5. Asia Pacific Transfusion Technology Market Attractiveness Analysis 
            11.5.1. By Product 
            11.5.2. By  End-user 
            11.5.3. By Country/Sub-region

12. Latin America Transfusion Technology Analysis and Forecast
     12.1. Introduction
            12.1.1. Key Findings
     12.2. Latin America Transfusion Technology Market Value Forecast, by Product, 2016–2026
            12.2.1. Instruments
                     12.2.1.1. Apheresis System & Multicomponent Collection Systems
                     12.2.1.2. Cell Processing Systems & Cell Expansion Systems 
                     12.2.1.3. Auto Transfusion Devices
                     12.2.1.4. Others 
            12.2.2. Disposables & Consumables
     12.3. Latin America Transfusion Technology Market Value Forecast, by  End-user, 2016–2026
            12.3.1. Hospitals 
            12.3.2. Blood Banks 
            12.3.3. Biotechnology & Pharmaceutical Companies 
            12.3.4. Others 
     12.4. Latin America Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Rest of Latin America
     12.5. Latin America Transfusion Technology Market Attractiveness Analysis 
            12.5.1. By Product 
            12.5.2. By  End-user 
            12.5.3. By Country/Sub-region

13. Middle East & Africa Transfusion Technology Analysis and Forecast
     13.1. Introduction
            13.1.1. Key Findings
     13.2. Middle East & Africa Transfusion Technology Market Value  Forecast, by Product, 2016–2026
            13.2.1. Instruments
                     13.2.1.1. Apheresis System & Multicomponent Collection Systems
                     13.2.1.2. Cell Processing Systems & Cell Expansion Systems 
                     13.2.1.3. Auto Transfusion Devices
                     13.2.1.4. Others 
            13.2.2. Disposables & Consumables
     13.3. Middle East & Africa Transfusion Technology Market Value Forecast, by  End-user, 2016–2026
            13.3.1. Hospitals 
            13.3.2. Blood Banks 
            13.3.3. Biotechnology & Pharmaceutical Companies 
            13.3.4. Others 
     13.4. Middle East & Africa Transfusion Technology Market Value Forecast, by Country/Sub-region, 2016–2026
            13.4.1. GCC Countries
            13.4.2. South Africa
            13.4.3. Rest of Middle East & Africa
     13.5. Middle East & Africa Transfusion Technology Market Attractiveness Analysis 
            13.5.1. By Product 
            13.5.2. By  End-user 
            13.5.3. By Country/Sub-region

14. Competition Landscape
     14.1. Market Player – Competition Matrix (By Tier and Size of companies)     
     14.2. Company Profiles 
            14.2.1. General Electric Healthcare
                     14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.1.2. Product Portfolio
                     14.2.1.3. SWOT Analysis
                     14.2.1.4. Strategic Overview     
                     14.2.1.5. Financial Overview
            14.2.2. Haemonetics Corporation 
                     14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.1.2. Product Portfolio
                     14.2.2.3. SWOT Analysis
                     14.2.2.4. Strategic Overview     
                     14.2.2.5. Financial Overview
            14.2.3. TERUMO BCT
                     14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.3.2. Product Portfolio
                     14.2.3.3. SWOT Analysis
                     14.2.3.4. Strategic Overview     
                     14.2.3.5. Financial Overview
            14.2.4. B. Braun Melsungen AG
                     14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.4.2. Product Portfolio
                     14.2.4.3. SWOT Analysis
                     14.2.4.4. Strategic Overview     
                     14.2.4.5. Financial Overview
            14.2.5. Fresenius Kabi AG
                     14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.5.2. Product Portfolio
                     14.2.5.3. SWOT Analysis
                     14.2.5.4. Strategic Overview     
                     14.2.5.5. Financial Overview
            14.2.6. Medtronic
                     14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.6.2. Product Portfolio
                     14.2.6.3. SWOT Analysis
                     14.2.6.4. Strategic Overview     
                     14.2.6.5. Financial Overview
            14.2.7. LivaNova PLC 
                     14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.7.2. Product Portfolio
                     14.2.7.3. SWOT Analysis
                     14.2.7.4. Strategic Overview     
                     14.2.7.5. Financial Overview
            14.2.8. Kawasumi Laboratories Inc.
                     14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.8.2. Product Portfolio
                     14.2.8.3. SWOT Analysis
                     14.2.8.4. Strategic Overview     
                     14.2.8.5. Financial Overview
            14.2.9. Lmb Technologie GmbH
                     14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.9.2. Product Portfolio
                     14.2.9.3. SWOT Analysis
                     14.2.9.4. Strategic Overview     
                     14.2.9.5. Financial Overview
            14.2.10. Miltenyi Biotec 
                     14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.10.2. Product Portfolio
                     14.2.10.3. SWOT Analysis
                     14.2.10.4. Strategic Overview     
                     14.2.10.5. Financial Overview
            14.2.11. Asahi Kasei Medical Co., Ltd. 
                     14.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.11.2. Product Portfolio
                     14.2.11.3. SWOT Analysis
                     14.2.11.4. Strategic Overview     
                     14.2.11.5. Financial Overview
            14.2.12. Cerus Corporation 
                     14.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
                     14.2.12.2. Product Portfolio
                     14.2.12.3. SWOT Analysis
                     14.2.12.4. Strategic Overview     
                     14.2.12.5. Financial Overview

List of Tables

Table 1: Global Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 2: Global Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 3: Global Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2015–2026
Table 4: Global Transfusion Technology Market Value (US$ Mn) Forecast, by Region, 2017–2026
Table 5: North America Transfusion Technology Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 6: North America Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 7: North America Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 8: North America Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 9: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 10: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 11: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 12: Europe Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 13: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 14: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 15: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 16: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 17: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016?2026
Table 18: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016?2026
Table 19: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 20: Latin America Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016?2026
Table 21: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 23: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by Product (Instruments), 2016–2026
Table 24: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Figures
 

Figure 1: Global Transfusion Technology Market Value (US$ Mn) and Distribution, by Geography, 2017 and 2026

Figure 2: Global Transfusion Technology Market Value (US$ Mn) Analysis, by Product, 2017

Figure 3: Global Transfusion Technology Market Value (US$ Mn) Analysis, by Instruments, 2017

Figure 4: Global Transfusion Technology Market Value (US$ Mn) Analysis, by End-user, 2017

Figure 5: Global Transfusion Technology Market Value (US$ Mn) Analysis, by Key Segment and Market Share (%), 2017

Figure 6: Global Transfusion Technology, Market Opportunity Map, by Product

Figure 7: Global Transfusion Technology, Market Opportunity Map, by Instrument

Figure 8: Global Transfusion Technology, Market Opportunity Map, by End-user

Figure 9: Key Industry Evolution/Developments

Figure 10: Global Transfusion Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026

Figure 11: Porter’s Five Force Analysis

Figure 12: Value Chain Analysis

Figure 13: Global Transfusion Technology Market Value Share, by Product (2017)

Figure 14: Global Transfusion Technology Market Value Share, by Region (2017)

Figure 15: Global Transfusion Technology Market Value Share, by End-user (2017)

Figure 16: Global Transfusion Technology Market Value Share Analysis, by Product, 2017 and 2026

Figure 17: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2016–2026

Figure 18: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Disposables & Consumables, 2016–2026

Figure 19: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Apheresis System & Multicomponent Collection Systems, 2016–2026

Figure 20: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Cell Processing Systems & Cell Expansion Systems, 2016–2026

Figure 21: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Auto Transfusion Devices, 2016–2026

Figure 22: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 23: Global Transfusion Technology Market Attractiveness Analysis, by Product, 2018-2026

Figure 24: Global Transfusion Technology Market Value Share, by End-user, 2017 and 2026

Figure 25: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals 2016–2026

Figure 26: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Blood Banks, 2016–2026

Figure 27: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2016–2026

Figure 28: Global Transfusion Technology Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026

Figure 29: Global Transfusion Technology Market Attractiveness, by End-user, 2017

Figure 30: Global Transfusion Technology Market Scenario

Figure 31: Global Transfusion Technology Market Value Share Analysis, by Region, 2018 and 2026

Figure 32: Transfusion Technology Market Attractiveness Analysis, by Region

Figure 33: North America Transfusion Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 34: North America Transfusion Technology Market Value Share, by Country, 2017 and 2026

Figure 35: North America Transfusion Technology Market Attractiveness, by Country, 2018–2026

Figure 36: North America Transfusion Technology Market Value Share, by Product, 2017 and 2026

Figure 37: North America Transfusion Technology Market Attractiveness, by Product, 2018–2026

Figure 38: North America Transfusion Technology Market Value Share, by End-user, 2017 and 2026

Figure 39: North America Transfusion Technology Market Attractiveness, by End-user, 2018–2026

Figure 40: Europe Transfusion Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 41: Europe Transfusion Technology Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 42: Europe Transfusion Technology Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 43: Europe Transfusion Technology Market Value Share, by Product, 2017 and 2026

Figure 44: Europe Transfusion Technology Market Attractiveness, by Product, 2018–2026

Figure 45: Europe Transfusion Technology Market Value Share, by End-user, 2017 and 2026

Figure 46: Europe Transfusion Technology Market Attractiveness, by End-user, 2018–2026

Figure 47: Asia Pacific Transfusion Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026

Figure 48: Asia Pacific Transfusion Technology Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 49: Asia Pacific Transfusion Technology Market Attractiveness, by Country/Sub-region, 2018?2026

Figure 50: Asia Pacific Transfusion Technology Market Value Share, by Product, 2017 and 2026

Figure 51: Asia Pacific Transfusion Technology Market Attractiveness, by Product, 2018?2026

Figure 52: Asia Pacific Transfusion Technology Market Value Share, by End-user, 2017 and 2026

Figure 53: Asia Pacific Transfusion Technology Market Attractiveness, by End-user, 2018?2026

Figure 54: Latin America Transfusion Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016?2026

Figure 55: Latin America Transfusion Technology Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 56: Latin America Transfusion Technology Market Attractiveness, by Country/Sub-region, 2018?2026

Figure 57: Latin America Transfusion Technology Market Value Share, by Product, 2017 and 2026

Figure 58: Latin America Transfusion Technology Market Attractiveness, by Product, 2018?2026

Figure 59: Latin America Transfusion Technology Market Value Share, by End-user, 2017 and 2026

Figure 60: Latin America Transfusion Technology Market Attractiveness, by End-user, 2018?2026

Figure 61: Middle East & Africa Transfusion Technology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026

Figure 62: Middle East & Africa Transfusion Technology Market Value Share, by Country/Sub-region, 2017 and 2026

Figure 63: Middle East & Africa Transfusion Technology Market Attractiveness, by Country/Sub-region, 2018–2026

Figure 64: Middle East & Africa Transfusion Technology Market Value Share, by Product, 2017 and 2026

Figure 65: Middle East & Africa Transfusion Technology Market Attractiveness, by Product, 2018–2026

Figure 66: Middle East & Africa Transfusion Technology Market Value Share, by End-user, 2017 and 2026

Figure 67: Middle East & Africa Transfusion Technology Market Attractiveness, by End-user, 2018–2026

Figure 68: Haemonetics Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017

Figure 69: Haemonetics Corporation Research and Development Expenses, 2013-2017

Figure 70: Haemonetics Corporation Breakdown of Net Sales (% Share), by Business Segment (2017)

Figure 71: Haemonetics Corporation Breakdown of Net Sales (% Share), by Region (2017)

Figure 72: Medtronic plc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017

Figure 73: Medtronic plc. Operating Profit (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Figure 74: Medtronic plc. Gross Profit (US$ Mn) and Y-o-Y Growth (%), 2015–2017

Figure 75: Medtronic plc. Breakdown of Net Sales (%), by Region, 2017

Figure 76: Medtronic plc. Breakdown of Customers (%), by Segment, 2017

Figure 77: Asahi Kasei Medical Co., Ltd. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017

Figure 78: Asahi Kasei Medical Co., Ltd. Research and Development Expenses, 2013-2017

Figure 79: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (% Share), by Business Segment (2017)

Figure 80: Asahi Kasei Medical Co., Ltd. Breakdown of Net Sales (% Share), by Region (2017)

Figure 81: Asahi Kasei Medical Co., Ltd. Healthcare Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017

Figure 82: B. Braun Melsungen AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017

Figure 83: B. Braun Melsungen AG R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 84: B. Braun Melsungen AG Breakdown of Net Sales, by Business Segment, 2017

Figure 85: B. Braun Melsungen AG Breakdown of Net Sales, by Region, 2017

Figure 86: Fresenius Kabi AG (Fresenius SE & Co. KGaA) Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017

Figure 87: Fresenius Kabi AG (Fresenius SE & Co. KGaA) Research and Development Expenses, 2013-2017

Figure 88: Fresenius Kabi AG (Fresenius SE & Co. KGaA) Breakdown of Net Sales (% Share), by Business Segment (2017)

Figure 89: Fresenius Kabi AG (Fresenius SE & Co. KGaA) Breakdown of Net Sales (% Share), by Region (2017)

Figure 90: TERUMO CORPORATION Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2017

Figure 91: TERUMO CORPORATION Research and Development Expenses, 2013-2017

Figure 92: TERUMO CORPORATION Breakdown of Net Sales (% Share), by Business Segment (2017)

Figure 93: TERUMO CORPORATION Breakdown of Net Sales (% Share), by Region (2017)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

572

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved